A blood test for tumor DNA helped predict who stays cancer-free after lung surgery
In the NeoCOAST-2 trial, published Oct. 25, 2026, in Nature, people with operable lung cancer whose tumor DNA disappeared from the blood during treatment before surgery had much longer event-free survival (hazard…